(continued)
- Zevaskyn (prademagene zamikeracel)
- Methotrexate (Rheumatrex, Trexall, and others)
- Verkazia (cyclosporine ophthalmic)
- Vevye (Cyclosporine Ophthalmic)
- Acitretin (Soriatane)
- Lithium (Lithobid, Eskalith, and others)
- Mycophenolate (Cellcept, Myfortic, and others)
- Leflunomide (Arava)
- Fludarabine (Fludara)
- Gemcitabine (Gemzar, Infugem)
- Iohexol (Omnipaque)
- Clofarabine (Clolar)
- Cytarabine (Cytosar-U, Depocyt)
- Levocarnitine (Carnitor)
- Cladribine (Leustatin)
- Azacitidine (Vidaza)
- Pralatrexate (Folotyn)
- Thioguanine (Tabloid)
- Nipent (pentostatin)
- Mercaptopurine (Purinethol, Purixan)
- Zubsolv (buprenorphine/naloxone)
- Brixadi (buprenorphine)
- Nelarabine (Arranon)
- Inqovi (Decitabine/Cedazuridine)
- Vyxeos (daunorubicin/cytarabine)
- Rezlidhia (olutasidenib)
- Tibsovo (ivosidenib)
- Azathioprine (Imuran, Azasan)
- Decitabine (Dacogen)
- Floxuridine (FUDR)
- What to Know About Imfinzi for Biliary Tract Cancer
- What to Know About Imfinzi for Non-Small-Cell Lung Cancer
- Stelara for Crohn’s Disease and Ulcerative Colitis
- What to Know About Erleada for Prostate Cancer
- Navigating Prostate Cancer: What to Know About Nubeqa
- Benlysta for Lupus
- Your Guide to Saphnelo for Lupus
- Adbry for Atopic Dermatitis: What You Need to Know
- Treating Breast Cancer with Trodelvy – What You Need to Know
- Navigating Psoriatic Arthritis With Otezla: What You Need to Know
- Navigating Psoriasis With Otezla: What You Need to Know